AEZS News and Press, Aeterna Zentaris Inc. From 05/03/21

– Over 20 years of industry experience in translating research into clinical development in a wide range of therapeutic areas of endocrinology and oncology CHARLESTON, S.C., May 03, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (&#x...

CHARLESTON, S.C., April 28, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced its Ann...

Which Penny Stocks Are Investors Watching Today? As another week of trading penny stocks commences, the options for making your watchlist are endless. Because there are thousands of penny stocks to watch , investors need to be picky when looking for the right one to buy. Now, it...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the stock market today! As you grab your coffee and get ready for another trading week ahead, a quick look at the top pre-market stock movers will help you get prepped for the day. Here are the t...

3 Robinhood Penny Stocks to Watch If You’ve Been Watching Biotech As far as biotech penny stocks go, the choices are almost limitless. But, just because there are many to choose from does not mean that they all have potential. Rather, it’s important to consider a few d...

– Company executing on growth strategy to build-out pipeline of development assets – Pivotal Phase 3 safety and efficacy study AEZS-130-P02 (“Study P02”) expected to commence in Q2 2021 – Strong balance sheet enables significant opt...

Aeterna Zentaris (AEZS) receives notice from Nasdaq that the company has regained compliance with the minimum $1.00 bid price per share requirement under Nasdaq’s Listing Rule.On July 29, 2020, the Company received notice from Nasdaq that its common stock failed to maintain a minimum b...

CHARLESTON, S.C., March 22, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced...

Will These 5 Penny Stocks Continue Climbing This Week? While March continues to be bullish for many penny stocks, investors are always looking toward the future. With over 70 million individuals in the U.S. who have received one dose of a vaccine, investors seem confident in the pandemi...

Gainers: Sigma Labs (SGLB) +162%.Check-Cap (CHEK) +110%.Rubius Therapeutics (RUBY) +69%.Luokung Technology (LKCO) +43%.Shaw Communications (SJR) +38%.RumbleON (RMBL) +38%.Aeterna Zentaris (AEZS) +31%.Baosheng Media (BAOS) +30%.Intec Pharma (NTEC) +29%.GenMark Diagnostics (GNMK)...